Skip to main content
Equibles
CMPS logo

CMPS · COMPASS Pathways plc · Metrics

Track CMPS — free

Use CMPS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CMPS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$11.81 +0.76 (+6.88%) At close · Oct 27 Q2 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$1.53B
Shares
138.48M
Volume · Oct 27 2.27M Avg daily vol (3M) 2.68M

CMPS metrics

67 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$11.81
Market cap
$1.53B

Price action

20 metrics
Price change (1W)
-0.5%
Price change (30D)
-16.5%
Price change (3M)
-2.0%
Price change (6M)
+24.3%
Price change (YTD)
+60.1%
Price change (1Y)
+76.0%
Trailing year
Price change (5Y)
-71.2%
52-week high
$15.19
52-week low
$4.94
Change from 52-week high
-27.3%
Change from 52-week low
+123.7%
Annualized volatility
90.2%
Annualized volatility (3M)
66.3%
Beta
1.6
RSI (14D)
39.4
Price vs SMA 50
-15.4%
Price vs SMA 200
+7.2%
Avg volume (3M)
2.69M
Relative volume
0.6
Average dollar volume
$35.12M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
138.48M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
18.1
reciprocal yield 5.5%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-25.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$181.76M
Net income (TTM)
−$394.19M
Trailing 12 months
Diluted EPS (TTM)
$-4.61
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-1.67
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-3.71
Operating cash flow per diluted share (TTM)
$-1.47
Free cash flow per diluted share (TTM)
$-1.76
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
$1.05
Stock compensation per diluted share (TTM)
$0.12
Book value per share
$-0.55

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+44.7%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-466.3%
Return on assets
-78.1%
Debt / equity
0.6
Current ratio
1.3
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.3
Interest coverage
-35.0
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$382.57M
Latest balance sheet
Cash & equivalents
$433.30M
Total assets
$504.56M
Total debt
$50.73M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$161.14M
Capital expenditures (TTM)
$0
R&D (TTM)
$112.89M
SG&A (TTM)
—
Stock compensation (TTM)
$12.98M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
226
13F filer change QoQ
+28
Institutional ownership
69.9%
Conviction holders (share of 13F filers)
4.5%
Crowding (high-turnover and private-fund holders)
43.2%
Private-fund adviser ownership
36.0%
Active holders' share change QoQ
-2.8%
Holder tenure
6.5
Price vs estimated holder cost
+100.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.7%

Short interest

3 metrics
Short interest
12.8%
Latest settlement · 6.8 days to cover
Days to cover
6.8d
Short-squeeze score
78 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1816590 CUSIP 20451W101 13F (30d) 44 filings 44 filers Visit website Investor relations